Reuters Health Information (2010-02-02): Simple ovarian cysts not linked to cancer in postmenopausal women

"Women with and without simple cysts were at similar risk of invasive ovarian cancer after nearly 8 years of follow-up evaluation, the authors write. Furthermore, traditional ovarian cancer risk factors, such as increasing age, family history of breast or ovarian cancer, nulliparity, and infertility, were not associated with simple cysts. Finally, changes in average CA-125 were not correlated with increases in the number or progression of simple cysts.Thus, Dr. Greenlee and his group conclude, "Simple cysts are not likely cancer precursors or markers of increased risk and can be followed conservatively.""

In Research: Charles Drew cancer studies with yeast yield excellent results

full free access: A novel germline PALB2 deletion in Polish breast and ovarian cancer patients

Conclusions:
The c.509_510delGA is a novel PALB2 mutation that increases the risk of familial breast cancer. Occurrence of the same PALB2 alteration in seven unrelated women suggests that c.509_510delGA (p.R170fs) is a recurrent mutation for Polish population.

First Canary Foundation Researcher Awarded SPORE in Ovarian Cancer Research - Dr Nicole Urban et al

Cochrane Symposium - Ottawa May 2010

Upcoming Cochrane Collaboration conference includes seminars for consumers/patients

Fertility-sparing surgery in young women with invasive epithelial ovarian cancer.

Note: this study also discusses tumour rupture/survival; the abstract does not include specific cell types, however, clear cell can be possibly presumed given the research data on Japanese women with clear cell ovarian cancer.

Patient with Eight Metachronous Gastrointestinal Cancers Thought to be Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Lynch Syndrome.

short abstract

Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival.

Value of medical practice guidelines questioned - Canadian Medical Association Journal

Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Note: The response rates in this study either alone or in combination were low. The side effects appear to be understated (abstract).

CDC - Cancer and Flu

Catheters and Ports in Cancer Treatment | Cancer.Net

Listings of different resources: Side Effects | Cancer.Net

(General) Matching Services to Find a Clinical Trial | Cancer.Net

(Basic/General) Questions to Ask the Research Team | Cancer.Net

Patient Advocate Foundation - Executive Board Members

Health-related behavior change after cancer: results of the American Cancer Society’s studies of cancer survivors (SCS)

The Miracle of Vitamin D: Sound Science, or Hype? - Well Blog - NYTimes.com

Drugs A-Z List - A on RxList

This is a useful website for finding a lot of information relating to drugs, including chemotherapies. It includes drug interactions, warnings, generic names, pill identifier, medical dictionary etc. The website has been around for many years.

ACOR in Time Magazine - 'Group Therapy'

Group Therapy - TIME Magazine - ACOR in Time Magazine

full free access: from the series - the Art of Oncology : "Pessimism Is No Poison"

"....The fellow asked the oncologist why he was so pessimistic when talking with the patient. Why did he say things to make the patient and her husband cry? Shouldn't he have given the patient more hope? Would it not have been better for the patient to hear this dire news in chunks over the course of several clinic visits? After all, the patient was so young she may just beat the odds....."